BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• 

  Editorial

  Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad

  The FDA has been trying to mend fences with rare disease drug developers and patient groups since the departure of former Commissioner Marty Makary three months ago. But advisory committee meetings last week for Replimune and Capricor Therapeutics only created more confusion and frustration.

  August 5, 2026

   · 

  6 min read

   · 

  Heather McKenzie
• Press Releases

  Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

  August 5, 2026

   · 

  1 min read
• Press Releases

  Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

  August 5, 2026

   · 

  5 min read
• Press Releases

  ImageneBio Reports Second Quarter 2026 Financial Results

  August 5, 2026

   · 

  11 min read
• Press Releases

  UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

  August 5, 2026

   · 

  21 min read
• Press Releases

  Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

  August 5, 2026

   · 

  8 min read
• Press Releases

  Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

  August 5, 2026

   · 

  4 min read
• Press Releases

  Kura Oncology to Report Second Quarter Financial Results

  August 5, 2026

   · 

  1 min read
• Press Releases

  CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference

  August 5, 2026

   · 

  1 min read
• Press Releases

  BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer

  August 5, 2026

   · 

  4 min read